$6.05 Billion is the total value of Hillhouse Capital Management's 48 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 79.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JD | Sell | JD COM INCspon adr cl a | $2,154,319,000 | -17.9% | 56,395,797 | -15.7% | 35.59% | -12.0% |
| MDLZ | Sell | MONDELEZ INTL INCcl a | $332,182,000 | -13.1% | 8,169,741 | -7.7% | 5.49% | -6.9% |
| PCLN | Sell | PRICELINE GRP INC | $205,678,000 | -56.9% | 112,342 | -56.0% | 3.40% | -53.8% |
| SINA | Sell | SINA CORPord | $78,474,000 | -35.0% | 684,466 | -51.8% | 1.30% | -30.3% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,703,000 | -21.2% | 231,033 | -5.9% | 0.04% | -15.1% |
| LC | Exit | LENDINGCLUB CORP | $0 | – | -100,000 | -100.0% | -0.01% | – |
| XNET | Exit | XUNLEI LTDsponsored adr | $0 | – | -403,041 | -100.0% | -0.02% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -725,000 | -100.0% | -0.04% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -120,000 | -100.0% | -0.05% | – |
| PYPL | Exit | PAYPAL HLDGS INC | $0 | – | -75,186 | -100.0% | -0.06% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -75,000 | -100.0% | -0.06% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -122,856 | -100.0% | -0.08% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -550,000 | -100.0% | -0.08% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -1,190,476 | -100.0% | -0.08% | – |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -352,300 | -100.0% | -0.10% | – |
| NBRV | Exit | NABRIVA THERAPEUTICS AGsponsored adr | $0 | – | -686,400 | -100.0% | -0.11% | – |
| V | Exit | VISA INC | $0 | – | -92,100 | -100.0% | -0.13% | – |
| FB | Exit | FACEBOOK INCcl a | $0 | – | -60,300 | -100.0% | -0.14% | – |
| WB | Exit | WEIBO CORPsponsored adr | $0 | – | -142,020 | -100.0% | -0.14% | – |
| CBPO | Exit | CHINA BIOLOGIC PRODS INC | $0 | – | -753,624 | -100.0% | -1.31% | – |
| YUMC | Exit | YUM CHINA HLDGS INC | $0 | – | -2,302,989 | -100.0% | -1.40% | – |
| MOMO | Exit | MOMO INCadr | $0 | – | -2,629,062 | -100.0% | -1.50% | – |
| ZTO | Exit | ZTO EXPRESS CAYMAN INCsponsored adr | $0 | – | -11,386,920 | -100.0% | -2.45% | – |
| CTRP | Exit | CTRIP COM INTL LTD | $0 | – | -4,812,246 | -100.0% | -4.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.